Biobank for patients with inflammatory chronic diseases and osteoporosis
Biobank for Inflammatory Chronic Diseases and Osteoporosis of TOULouse
This study is creating a biobank to collect samples from patients with chronic inflammatory diseases and osteoporosis to see if they can find markers that help doctors choose better treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT05039216 on ClinicalTrials.gov |
What this trial studies
This study aims to create a biobank for patients at the Rheumatology center of Toulouse University Hospital who have chronic inflammatory rheumatism, such as rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis, as well as those with osteoporosis. By collecting and storing biological samples from these patients, the study seeks to identify biomarkers that are associated with therapeutic responses to various treatments. This will help physicians make more informed decisions regarding treatment options based on predictive clinical and biological factors. The biobank will also focus on understanding the severity of osteoporosis and the effectiveness of anti-osteoporotic treatments.
Who should consider this trial
Good fit: Ideal candidates include individuals with rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, or osteoporosis who are starting a new treatment.
Not a fit: Patients who are pregnant, breastfeeding, unable to consent, or have severe anemia will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for patients with chronic inflammatory diseases and osteoporosis.
How similar studies have performed: Other studies have shown success in identifying biomarkers for treatment responses in similar chronic inflammatory conditions, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis * With National Health Assurance * Able to consent to the study Exclusion Criteria: * Pregnancy or breastfeeding * Not able to give a consent * Severe anemia (Hb\<10g/L)
Where this trial is running
Toulouse
- Purpan University Hospital — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Adeline RUYSSEN-WITRAND, MD — University Hospital, Toulouse
- Study coordinator: Adeline RUYSSEN-WITRAND, MD
- Email: ruyssen-witrand.a@chu-toulouse.fr
- Phone: 561775626
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.